RxDoctor Payments Data

Peter Bushunow, MD

Medical Oncology · Rochester, NYNPI 1619915402

Payments from drug & device makers

$146,848in general payments, 2019–2025

Across 21 payments — averaging $6992.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Products Limited$130K
  • Jazz Pharmaceuticals Inc.$17K
  • E.r. Squibb & Sons, L.L.C.$25
  • Acrotech Biopharma Inc.$14
  • Gilead$12

What the payments were for

  • Food & beverage$2550%
  • Education$2650%

General payments by program year

19
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$146,848 in reported general payments places this provider in the 50th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York

Medicare billing

Part B allowed, 2024
$12,655
Medicare patients
54
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole54$1,089
Tamoxifen Citrate23$548
Prochlorperazine Maleate40$488
Dexamethasone15$273
Prednisone20$73

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →